AlphaVax
Durham
About AlphaVax
AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer. It uses alphavaccine vector platform technology to generate a portfolio of vaccine candidates for infectious disease prevention and cancer immunotherapy. AlphaVax was founded by Jonathan F. Smith and is based in Durham, North Carolina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $48.4M
- Funding stage: Late Stage Venture
- Last round: Series E (Feb 2007)
- Website: alphavax.com
- Phone: 919-595-0400
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/alphavax-2223896 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.